Abstract
Monocytes express tissue factor (mTF) in several conditions including cancer where levels may be valuable in assessing tumour presence and progression. Using a two-stage kinetic chromogenic assay (KCA), mTF levels were measured in controls [normal subjects (n = 60) and patients undergoing hernia repair or cholecystectomy (n = 60)], in patients with benign and malignant disease of the breast (n = 83) and of the large bowel (n = 62). This was performed under fresh (resting) conditions and after incubation for 6 h without (unstimulated) and with (stimulated) Escherichia coli endotoxin. The malignant groups showed higher mTF levels than each of the three controls for resting (P < 0.05 breast, P < 0.05 colorectal) unstimulated (P < 0.05 breast, P < 0.05 colorectal) and stimulated cells (P < 0.001 breast, P < 0.01 colorectal). Similarly, the benign inflammatory groups had higher mTF levels than controls for resting (P < 0.05 colorectal), unstimulated (P < 0.05 colorectal) and stimulated cells (P < 0.01 breast, P < 0.01 colorectal). There was no significant difference between malignant and benign inflammatory groups in each organ. mTF levels showed an increase corresponding to that of histological tumour progression and were higher in non-surviving patients. In conclusion, mTF levels are raised in malignant and inflammatory disease compared to controls and patients with non-inflammatory conditions. Stimulated cells give better discrimination between the groups and may be of value in identifying high risk individuals. mTF levels showed an association with tumour grade or stage and the patients’ survival time.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Auger, M. J. & Mackie, M. J. (1987) Monocyte procoagulant activity in breast cancer. Thromb Res 47: 77–84.
Bach, R. R., Nemrson, Y. & Konigsberg, W. K. (1981) Purification and characterization of bovine tissue factor. J Biol Chem 256: 8324–8331.
Carson, S. D. & Konisberg, W. H. (1980) Cadmium increases tissue factor (coagulation factor III) activity by facilitating its reassociation with lipids. Science 208: 307–309.
Carvalho, M. G. (1995). Monocyte tissue factor in malignancy. PhD thesis. Southampton University
Contrino, J., Hair, G., Kreutzer, D. & Rickles, F. R. (1996) In situ detection of expression of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast tissue. Nature Med 2: 209–215.
Dasmahapatra, K. S., Cheung, N. K., Spillert, C. & Lazaro, E. (1987) An assessment of monocytes procoagulant activity in patients with solid tumours. J Surg Res 43: 158–163.
Edwards, R. L., Rickles, F. R. & Cronlund, M. (1981) Abnormalities of blood coagulation in patients with cancer. Mononuclear cell tissue factor generation. J Lab Clin Med 98: 917–928.
Edwards, R. L., Levine, J. B., Green, R., Duffy, M., Mathews, E., Brande, W. & Rickles, F. R. (1987) Activation of blood coagulation in Crohn’s disease: Increased fibrinopeptide A levels and enhanced generation of monocyte tissue factor activity. Gastroenterology 92: 329–337.
El-Baruni (1990). Factor X-activating procoagulant in normal and malignant breast tumour. PhD thesis. Southampton University
Francis, J. L., Carvalho, M. & Francis, D. A. (1995) The clinical value of tissue factor assays. Blood Coag Fibrinol 6: 37–44.
Guha, A., Bach, R. R., Konigsberg, W. & Nemerson, Y. (1986) Affinity purification of human tissue factor. Interaction of factor VII and tissue factor in detergents micelles. Proc Natl Acad Sci USA 83: 299–302.
Hogg, N. (1983) Human monocytes are associated with the formation of fibrin. J Exp Med 157: 473–485.
Lorenzet, R., Peri, G., Locati, D., Allavena, P., Colucci, M., Semeraro, N., Mantovanti, A. & Donati, M. B. (1983) Generation of procoagulant activity by mononuclear phagocytes: a possible mechanism contributing to blood clotting activation within malignant tissues. Blood 62: 271–273.
Lwaleed, B. A., Chisholm, M. & Francis, J. L. (1997) Elevated blood monocyte tissue factor levels in patients with cancer (Abstract). Br J Cancer 75: 45
Lwaleed, B. A., Chisholm, M. & Francis, J. L. (1999) Urinary tissue factor levels in patients with breast and colorectal cancer. J Pathol 187: 291–294.
Mellor, H., Taylor, I., Roath, S. & Francis, J. L. (1989) Whole blood procoagulant activity in breast and colorectal cancer. J Clin Pathol 42: 489–494.
Morgan, D., Edwards, R. L. & Rickles, F. R. (1988) Monocyte procoagulant activity as a peripheral marker of clotting activation in cancer patients. Haemostasis 18: 55–65.
Muller, A. D., van Dam-Mieras, M. C. E. & Hemker, H. C. (1985) Measurement of macrophage cellular procoagulant activity. Haemostasis 15: 108–113.
Naschitz, J. E., Yeshurun, D., Eldar, S. & Lev, L. M. (1996) Diagnosis of cancer-associated vascular disorders. Cancer 77: 1759–1767.
Nemerson, Y. (1992) The tissue factor pathway of blood coagulation. Semin Haemost 29: 170–176.
Nemerson, Y. & Bach, R. (1982) Tissue factor revisited. Prog Hemost Thromb 6: 237–261.
Nemerson, Y. & Gentry, R. (1986) An ordered addition, essential activation of model of the tissue factor pathway of coagulation: evidence for conformational change. Biochemistry 25: 4020–4033.
Østerud, B. & Bjorkild, E. (1982) The production and availability of tissue thromboplastin in cellular populations of whole blood exposed to various concentration of endotoxin: an assay for detection of endotoxin. Scand J Haematol 29: 175–184.
Østerud, B. & Due, Jr J. (1984) Blood coagulation in patients with benign and malignant tumours before and after surgery. Special reference to thromboplastin generation in monocytes. Scand J Haematol 32: 258–264.
Østerud, B. & Flaegstad, T. (1983) Increased thromboplastin activity in monocytes of patients with meningococcal infection: related to an unfavourable prognosis. Thromb Haemost 49: 5–7.
Østerud, B., Olsen, J. O. & Wilsgard, L. (1990) The role of arachidonic acid release and lipoxygenase pathway in lipopolysaccharide-induced thromboplastin activity in monocytes. Blood Coagul Fibrinol 1: 41–46.
Parmar, J., Taylor, I., Roath, O. S. & Francis, J. L. (1990) Procoagulant activity in whole blood from patients with breast and colorectal cancer. Blood Coag Fibrinol 1: 127–132.
Szczepanski, M., Bardadin, K., Zawadzki, J. & Pypno, W. (1988) Procoagulant activity of gastric, colorectal, and renal-cancer is factor-VII-dependent. J Cancer Res Clin Oncol 114: 519–522.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Lwaleed, B., Chisholm, M. & Francis, J. The significance of measuring monocyte tissue factor activity in patients with breast and colorectal cancer. Br J Cancer 80, 279–285 (1999). https://doi.org/10.1038/sj.bjc.6690352
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690352